Skip to main navigation Skip to search Skip to main content

Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affects the antitumor activity of doxorubicin.

  • S.A.B.E. van Acker
  • , E. Boven
  • , K. Kuiper
  • , D.J. van den Berg
  • , J.A. Grimbergen
  • , K. Kramer
  • , A. Bast
  • , W.J.F. van der Vijgh

    Research output: Contribution to JournalArticleAcademicpeer-review

    Original languageEnglish
    Pages (from-to)1747-1754
    JournalClinical Cancer Research
    Volume3
    Publication statusPublished - 1997

    Cite this